New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites at 5 Second Scrub Time

PDI Prevantics® Device Swab is the only 3.15% Chlorhexidine Gluconate/70% alcohol solution to receive market authorization by the FDA

News provided by

PDI

Oct 21, 2014, 09:30 ET

ORANGEBURG, N.Y., Oct. 21, 2014 /PRNewswire/ -- Clinical investigators recently released results from the first and only randomized, cross-over, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate (CHG) and 70% Isopropyl Alcohol over 70% Isopropyl Alcohol alone in disinfecting needleless connectors. The study was funded by the US Centers for Disease Control and Prevention (CDC) Epicenters Program and executed by Rush University in Chicago, IL. The results were presented at the 2014 IDWeek Conference in Philadelphia, PA, on October 11, 2014.

The findings align with CDC Guidelines which state: "Some studies have shown that disinfection of the devices with chlorhexidine/alcohol solutions appears to be most effective in reducing colonization."¹ The investigators determined that the CHG and alcohol scrub resulted in less needleless connector contamination than an alcohol scrub at a five second scrub time. Prevantics^®Device Swab from PDI, leading provider of infection prevention solutions, is the only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol solution that has received market authorization from the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use.

"This study answers a previously unknown clinical question about the most efficacious antiseptic for disinfection of needleless access sites and also ideal prep times," said Hudson Garrett, PhD, Vice-President, Clinical Affairs for PDI. "This study demonstrates the importance of targeted efforts to reduce contamination on needleless access sites and ensure evidence-based practices for disinfection of needleless access sites."

The PDI Prevantics^® Device Swab is fully compliant with the evidence-based guidelines and recommendations from the US Centers for Disease Control and Prevention (CDC), the Infusion Nurses Society, the Association for Vascular Access, and the Association for Professionals in Infection Control and Epidemiology.

About PDI
PDI helps reduce preventable infections, control healthcare costs, and ultimately help save lives by delivering a broad range of evidence-based, market leading skin antisepsis, environmental hygiene and patient care solutions. PDI's expertise in making a difference in the community and healthcare environments extends throughout the United States and worldwide. pdihc.com

¹ 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections, Healthcare Infection Control Practices Advisory Committee, US Centers for Disease Control and Prevention, 2011

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-randomized-study-shows-315-chlorhexidine-gluconate70-isopropyl-alcohol-solution-most-effective-for-disinfecting-needleless-access-sites-at-5-second-scrub-time-318510575.html

SOURCE PDI